Geode Capital Management LLC raised its holdings in shares of NeuroOne Medical Technologies Co. (NASDAQ:NMTC – Free Report) by 9.6% during the third quarter, Holdings Channel.com reports. The fund owned 283,855 shares of the company’s stock after buying an additional 24,972 shares during the period. Geode Capital Management LLC’s holdings in NeuroOne Medical Technologies were worth $281,000 at the end of the most recent reporting period.
Separately, XTX Topco Ltd bought a new stake in NeuroOne Medical Technologies during the third quarter valued at about $26,000. 16.07% of the stock is owned by institutional investors and hedge funds.
NeuroOne Medical Technologies Stock Down 1.0 %
NASDAQ:NMTC opened at $1.12 on Tuesday. The business’s 50-day simple moving average is $0.80 and its two-hundred day simple moving average is $0.84. The stock has a market cap of $34.54 million, a PE ratio of -2.33 and a beta of 0.41. NeuroOne Medical Technologies Co. has a 52 week low of $0.55 and a 52 week high of $1.59.
NeuroOne Medical Technologies Profile
NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson’s disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders.
See Also
- Five stocks we like better than NeuroOne Medical Technologies
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- 2 Stocks to Gain From Trump Universal Tariffs on Critical Imports
- Using the MarketBeat Dividend Yield Calculator
- Rigetti Computing, Inc.: Buy, Sell, or Hold for 2025
- Investing In Preferred Stock vs. Common Stock
- Delta Can Fly to New Highs in 2025; Here’s Why
Want to see what other hedge funds are holding NMTC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for NeuroOne Medical Technologies Co. (NASDAQ:NMTC – Free Report).
Receive News & Ratings for NeuroOne Medical Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NeuroOne Medical Technologies and related companies with MarketBeat.com's FREE daily email newsletter.